O. Salamero

发表论文 166 篇 · 总被引 1712 次 · h-index 23

代表论文

• Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication–Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study (2025 · Journal of Clinical Oncology · 被引 14)
• Bleximenib in combination with intensive chemotherapy: A phase 1b study in newly diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 alterations (2025 · Blood · 被引 14)
• Phase 1b study of bleximenib in combination with venetoclax in Acute Myeloid Leukemia with KMT2A or NPM1 alterations (2025 · Blood · 被引 6)
• AML-418: Recommended Phase 2 Dose (RP2D) Determination of Bleximenib in Combination With Venetoclax+Azacitidine (VEN+AZA): Phase Ib Study in Newly Diagnosed (ND) and Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) With KMT2A or NPM1 Alterations (2025 · Clinical Lymphoma, Myeloma & Leukemia · 被引 4)
• Bleximenib in Combination with Intensive Chemotherapy: A phase 1b Study in Patients with Newly Diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 Alterations (2026 · Transplantation and Cellular Therapy · 被引 2)
• A scoring system to predict life-threatening thrombo-ischemic events in patients with acute promyelocytic leukemia: the PETHEMA/PALG study (2025 · Haematologica · 被引 2)